173 related articles for article (PubMed ID: 3469184)
1. Pharmacokinetics and tolerance after repeated doses of imipenem/cilastatin in patients with severe renal failure.
Verbist L; Verpooten GA; Giuliano RA; Debroe ME; Buntinx AP; Entwistle LA; Jones KH
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():115-20. PubMed ID: 3469184
[TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetics of imipenem (thienamycin-formamidine) and the renal dehydropeptidase inhibitor cilastatin sodium in normal subjects and patients with renal failure.
Verpooten GA; Verbist L; Buntinx AP; Entwistle LA; Jones KH; De Broe ME
Br J Clin Pharmacol; 1984 Aug; 18(2):183-93. PubMed ID: 6593092
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of imipenem-cilastatin in neonates.
Freij BJ; McCracken GH; Olsen KD; Threlkeld N
Antimicrob Agents Chemother; 1985 Apr; 27(4):431-5. PubMed ID: 3859242
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic studies of imipenem/cilastatin in elderly patients.
Finch RG; Craddock C; Kelly J; Deaney NB
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():103-7. PubMed ID: 3469182
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of imipenem and cilastatin in patients with cystic fibrosis.
Reed MD; Stern RC; O'Brien CA; Yamashita TS; Myers CM; Blumer JL
Antimicrob Agents Chemother; 1985 Apr; 27(4):583-8. PubMed ID: 3859245
[TBL] [Abstract][Full Text] [Related]
6. Multiple-dose pharmacokinetics of imipenem-cilastatin.
Drusano GL; Standiford HC; Bustamante C; Forrest A; Rivera G; Leslie J; Tatem B; Delaportas D; MacGregor RR; Schimpff SC
Antimicrob Agents Chemother; 1984 Nov; 26(5):715-21. PubMed ID: 6595963
[TBL] [Abstract][Full Text] [Related]
7. An overview of the pharmacology of imipenem/cilastatin.
Drusano GL
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():79-92. PubMed ID: 3546249
[TBL] [Abstract][Full Text] [Related]
8. Single-dose pharmacokinetics of imipenem-cilastatin in neonates.
Gruber WC; Rench MA; Garcia-Prats JA; Edwards MS; Baker CJ
Antimicrob Agents Chemother; 1985 Apr; 27(4):511-4. PubMed ID: 3859243
[TBL] [Abstract][Full Text] [Related]
9. Multiple-dose study of imipenem/cilastatin in patients with end-stage renal disease undergoing long-term hemodialysis.
Berman SJ; Sugihara JG; Nakamura JM; Kawahara KK; Wong EG; Musgrave JE; Wong LM; Siemsen AM
Am J Med; 1985 Jun; 78(6A):113-6. PubMed ID: 3859209
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of imipenem and cilastatin in volunteers.
Rogers JD; Meisinger MA; Ferber F; Calandra GB; Demetriades JL; Bland JA
Rev Infect Dis; 1985; 7 Suppl 3():S435-46. PubMed ID: 3863219
[TBL] [Abstract][Full Text] [Related]
11. Renal clearance of imipenem in children.
Jacobs RF; Kearns GL; Brown AL; Trang JM; Kluza RB
Eur J Clin Microbiol; 1984 Oct; 3(5):471-4. PubMed ID: 6594236
[TBL] [Abstract][Full Text] [Related]
12. Imipenem/cilastatin: the first carbapenem antibiotic.
Lyon JA
Drug Intell Clin Pharm; 1985 Dec; 19(12):895-9. PubMed ID: 3910385
[TBL] [Abstract][Full Text] [Related]
13. Single-dose pharmacokinetics of imipenem-cilastatin in pediatric patients.
Engelhard D; Shalit I; Stutman HR; Greenwood R; Griffis J; Marks MI
Pediatr Pharmacol (New York); 1986; 5(4):273-9. PubMed ID: 3461422
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of imipenem and cilastatin after their simultaneous administration to the elderly.
Toon S; Hopkins KJ; Garstang FM; Aarons L; Rowland M
Br J Clin Pharmacol; 1987 Feb; 23(2):143-9. PubMed ID: 3470047
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic profile of imipenem/cilastatin in normal volunteers.
Drusano GL; Standiford HC
Am J Med; 1985 Jun; 78(6A):47-53. PubMed ID: 3859215
[TBL] [Abstract][Full Text] [Related]
16. Imipenem/cilastatin: pharmacokinetic profile in renal insufficiency.
Gibson TP; Demetriades JL; Bland JA
Am J Med; 1985 Jun; 78(6A):54-61. PubMed ID: 3859216
[TBL] [Abstract][Full Text] [Related]
17. The plasma pharmacokinetics of high dose (1 g) imipenem coadministered with 1 g cilastatin in six normal volunteers.
Drusano GL; Standiford HC; Bustamante CI; Forrest A; Rivera G; Tatem B; Schimpff SC
Eur J Clin Microbiol; 1984 Oct; 3(5):468-70. PubMed ID: 6594235
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of imipenem/cilastatin in patients with severe bacterial infections.
Reutter FW
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():141-4. PubMed ID: 3469186
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy, safety and tolerability of intramuscular imipenem/cilastatin in the treatment of mild to moderate infections.
Garau J; Casagrán A; Sánchez C; Matas E
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():181-3. PubMed ID: 3469192
[TBL] [Abstract][Full Text] [Related]
20. Imipenem/cilastatin: a multicentre international study of its clinical efficacy, safety and potential as empirical therapy.
Wang C; Pappas F; Cook T
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():185-91. PubMed ID: 3469193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
